The global pharmaceutical Ranbaxy Laboratories plans to expand its Mohali facility starting 2014, primarily to meet the increase in demand from the US market. The drug maker’s existing SEZ (special economic zone) facility in Mohali manufactures oral solid products for export to the US, the European Union and other geographies. The facility is relatively new and received approval from the US regulatory authorities in October last year. However, it assumed significance in Ranbaxy’s
Ranbaxy drug facilities, Ranbaxy Laboratories, Mohali facility ranbaxy, ranbaxy approval facility, ranbaxy in Mohali
No comments:
Post a Comment